Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (12): 1296-1300.doi: 10.11958/20240945
• Clinical Research • Previous Articles Next Articles
YAO Qian(), WANG Jing, CHENG Na
Received:
2024-07-17
Revised:
2024-09-10
Published:
2024-12-15
Online:
2024-12-17
YAO Qian, WANG Jing, CHENG Na. Observation of curative effect of Shenqu Xiaoshi oral liquid on rotavirus infectious diarrhea in children[J]. Tianjin Medical Journal, 2024, 52(12): 1296-1300.
CLC Number:
组别 | n | 显效 | 有效 | 无效 | 总有效 |
---|---|---|---|---|---|
对照组 | 100 | 24(24.0) | 58(58.0) | 18(18.0) | 82(82.0) |
试验组 | 100 | 45(45.0) | 49(49.0) | 6(6.0) | 94(94.0) |
χ2 | 6.818* |
Tab.1 Comparison of clinical efficacy between the two groups
组别 | n | 显效 | 有效 | 无效 | 总有效 |
---|---|---|---|---|---|
对照组 | 100 | 24(24.0) | 58(58.0) | 18(18.0) | 82(82.0) |
试验组 | 100 | 45(45.0) | 49(49.0) | 6(6.0) | 94(94.0) |
χ2 | 6.818* |
组别 | 治疗前 | 治疗后 | t |
---|---|---|---|
对照组 | 14.13±3.72 | 7.65±2.12 | 15.606* |
试验组 | 13.89±3.65 | 4.74±1.46 | 24.291* |
t | 0.461 | 11.288* |
Tab.2 Comparison of traditional Chinese medicine syndrome scores between the two groups
组别 | 治疗前 | 治疗后 | t |
---|---|---|---|
对照组 | 14.13±3.72 | 7.65±2.12 | 15.606* |
试验组 | 13.89±3.65 | 4.74±1.46 | 24.291* |
t | 0.461 | 11.288* |
组别 | n | 止泻时间/h | 轮状病毒转阴率 |
---|---|---|---|
对照组 | 100 | 42.55±11.72 | 65(65.0) |
试验组 | 100 | 29.62±8.74 | 88(88.0) |
t或χ2 | 8.846* | 14.713* |
Tab.3 Comparison of diarrhea stopping time and negative conversion rate of fecal rotavirus between the two groups
组别 | n | 止泻时间/h | 轮状病毒转阴率 |
---|---|---|---|
对照组 | 100 | 42.55±11.72 | 65(65.0) |
试验组 | 100 | 29.62±8.74 | 88(88.0) |
t或χ2 | 8.846* | 14.713* |
组别 | IL-6/(ng/L) | TNF-α/(ng/L) | INF-γ/(ng/L) | hs-CRP/(mg/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
对照组 | 26.68±5.87 | 19.76±4.35 | 10.075* | 30.89±5.78 | 19.48±5.16 | 14.099* | 49.71±7.88 | 24.42±3.47 | 29.372* | 8.29±1.18 | 4.37±0.78 | 27.665* |
试验组 | 27.15±6.15 | 14.73±3.45 | 17.577* | 31.57±5.91 | 11.43±3.37 | 28.733* | 50.09±7.95 | 14.79±1.97 | 43.105* | 8.17±1.26 | 2.23±0.37 | 43.023* |
t | 0.541 | 9.071* | 0.823 | 13.063* | 0.348 | 24.170* | 0.638 | 24.609* |
Tab.4 Comparison of serum inflammatory factors between the two groups
组别 | IL-6/(ng/L) | TNF-α/(ng/L) | INF-γ/(ng/L) | hs-CRP/(mg/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
对照组 | 26.68±5.87 | 19.76±4.35 | 10.075* | 30.89±5.78 | 19.48±5.16 | 14.099* | 49.71±7.88 | 24.42±3.47 | 29.372* | 8.29±1.18 | 4.37±0.78 | 27.665* |
试验组 | 27.15±6.15 | 14.73±3.45 | 17.577* | 31.57±5.91 | 11.43±3.37 | 28.733* | 50.09±7.95 | 14.79±1.97 | 43.105* | 8.17±1.26 | 2.23±0.37 | 43.023* |
t | 0.541 | 9.071* | 0.823 | 13.063* | 0.348 | 24.170* | 0.638 | 24.609* |
组别 | CD3+/% | CD4+/% | CD8+/% | CD4+/CD8+ | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
对照组 | 59.89±6.88 | 66.86±7.05 | 6.641* | 38.16±5.63 | 43.23±4.59 | 7.053* | 30.85±3.43 | 28.56±3.15 | 4.986* | 1.26±0.29 | 1.55±0.47 | 12.165* |
试验组 | 60.47±7.34 | 70.39±7.47 | 10.031* | 38.82±5.86 | 47.76±5.03 | 10.982* | 31.12±3.66 | 24.77±2.86 | 14.406* | 1.22±0.25 | 1.93±0.54 | 24.731* |
t | 0.586 | 3.439* | 0.824 | 6.674* | 0.539 | 8.894* | 0.787 | 5.308* |
Tab.5 Comparison of immune function indexes between the two groups
组别 | CD3+/% | CD4+/% | CD8+/% | CD4+/CD8+ | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
对照组 | 59.89±6.88 | 66.86±7.05 | 6.641* | 38.16±5.63 | 43.23±4.59 | 7.053* | 30.85±3.43 | 28.56±3.15 | 4.986* | 1.26±0.29 | 1.55±0.47 | 12.165* |
试验组 | 60.47±7.34 | 70.39±7.47 | 10.031* | 38.82±5.86 | 47.76±5.03 | 10.982* | 31.12±3.66 | 24.77±2.86 | 14.406* | 1.22±0.25 | 1.93±0.54 | 24.731* |
t | 0.586 | 3.439* | 0.824 | 6.674* | 0.539 | 8.894* | 0.787 | 5.308* |
[1] | HUA S. Clinical value of zinc combined with folic acid in the treatment of infantile diarrhea[J]. Minerva Gastroenterol(Torino), 2024, 70(3):383-385. doi:10.23736/S2724-5985.23.03516-7. |
[2] | 中华中医药学会儿科分会, 中华中医药学会中药临床药理分会. 小儿腹泻中药临床试验设计与评价技术指南[J]. 药物评价研究, 2020, 43(4):660-664. |
Pediatric Branch of China Association of Chinese Medicine, Chinese Medicine Clinical Pharmacology Branch of China Association of Chinese Medicine. Guideline on design and evaluation of clinical trials for Chinese medicine in common pediatric disease:Diarrhea[J]. Drug Evaluation Research, 2020, 43(4):660-664. doi:10.7501/j.issn.1674-6376.2020.04.013. | |
[3] | 徐嘉辉, 张畅, 陈丽君, 等. 脾胃康颗粒口服联合中药热敷辅助治疗小儿轮状病毒感染性腹泻脾虚湿热证40例临床观察[J]. 中医儿科杂志, 2022, 18(3):49-53. |
XU J H, ZHANG C, CHEN L J, et al. Clinical observation on 40 cases of pediatric rotavirus-induced diarrhea with damp-heat due to spleen-asthenia syndrome treated by oral administration of Piweikang Keli combined with Chinese materia medica fomentation as adjuvant therapy[J]. J Pediatrics TCM, 2022, 18(3):49-53. doi:10.16840/j.issn1673-4297.2022.03.15. | |
[4] | 史卜文, 李利寻, 谢雁鸣, 等. 真实世界喜炎平注射液治疗3846例细菌性肠道感染患者临床用药特征分析[J]. 中国药物警戒, 2023, 20(9):1017-1021,1026. |
SHI B W, LI L X, XIE Y M, et al. Clinical characteristics of Xiyanping injection in 3846 patients with bacterial intestinal infection in the real world[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9):1017-1021,1026. doi:10.19803/j.1672-8629.20220061. | |
[5] | 陈词. 神曲消食口服液治疗小儿腹泻的效果及对炎症因子水平的影响[J]. 中国现代药物应用, 2023, 17(12):95-97. |
CHEN C. Effect of Shenqu Xiaoshi Oral Liquid on the treatment of diarrhea in children and its influence on the level of inflammatory factors[J]. Chin J Mod Drug Appl, 2023, 17(12):95-97. doi:10.14164/j.cnki.cn11-5581/r.2023.12.026. | |
[6] | 江载芳, 申昆玲, 沈颖. 诸福棠实用儿科学[M]. 8版. 北京: 人民卫生出版社, 2015:941-949. |
JIANG Z F, SHEN K L, SHEN Y. Zhu Futang Practical Pediatrics[M]. 8th Ed. Beijing: People's Medical Publishing House, 2015:941-949. | |
[7] | 中华中医药学会儿科分会临床评价学组. 小儿轮状病毒性肠炎中药新药临床试验设计与评价技术指南[J]. 药物评价研究, 2015, 38(4):350-356. |
Clinical Evaluation Unit, Pediatric Branch of China Association for Traditional Chinese Medicine. Guideline on evaluation of Chinese medical research for treatment of rotavirus gastroenteritis in children[J]. Drug Evaluation Research, 2015, 38(4):350-356. doi:10.7501/j.issn.1674-6376.2015.04.002. | |
[8] | LAKER G, NANKUNDA J, MELVIS B M, et al. Prevalence and factors associated with rotavirus diarrhea among children aged 3-24 months after the introduction of the vaccine at a referral hospital in Uganda:a cross-sectional study[J]. BMC Pediatr, 2024, 24(1):358. doi:10.1186/s12887-024-04842-8. |
[9] | 王明雯, 李静欣, 高升辉, 等. 2019年我国5岁以下腹泻住院患儿A组轮状病毒感染的流行特征分析[J]. 中华实验和临床病毒学杂志, 2022, 36(2):172-175. |
WANG M W, LI J X, GAO S H, et al. Epidemiological characteristics of group A rotavirus infection in hospitalized children under 5 years of age with diarrhea in China in 2019[J]. Chinese Journal of Experimental and Clinical Virology, 2022, 36(2):172-175. doi:10.3760/cma.j.cn112866-20211230-00217. | |
[10] | 徐秀营, 王绍杰. 布拉氏酵母菌散联合蒙脱石散治疗小儿轮状病毒感染性腹泻的效果及对免疫功能的影响[J]. 临床医学研究与实践, 2022, 7(18):80-82. |
XU X Y, WANG S J. Effect of Saccharomyces boulardii sachets combined with montmorillonite powder on Rotavirus infectious diarrhea in children and its influence on immune function[J]. Clinical Research and Practice, 2022, 7(18):80-82. doi:10.19347/j.cnki.2096-1413.202218022. | |
[11] | 张旭, 李玢, 陈海根, 等. 利巴韦林单用与联用喜炎平注射液治疗轮状病毒肠炎患儿的疗效对比的Meta分析[J]. 中外医疗, 2023, 42(14):129-133. |
ZHANG X, LI F, CHEN H G, et al. Meta-analysis of the efficacy of ribavirin alone and combination with Xi-yanping injection in the treatment of children with rotavirus enteritis[J]. China & Foreign Medical Treatment, 2023, 42(14):129-133. doi:10.16662/j.cnki.1674-0742.2023.14.129. | |
[12] | 中国中西医结合学会儿科分会消化学组. 神曲消食口服液临床应用指导意见(2021-08-30)[J]. 世界中医药, 2021, 16(22):3265-3269. |
Gastroenterology Group of Pediatric Specialty Committees, China Society of Integrated Traditional Chinese and Western Medicine. Guidelines on clinical application of Shenqu Xiaoshi oral liquid(2021-08-30)[J]. World Chinese Medicine, 2021, 16(22):3265-3269. doi:10.3969/j.issn.1673-7202.2021.22.001. | |
[13] | 文伟, 黄金华, 刘燕青, 等. 神曲消食口服液联合锌制剂佐治小儿腹泻50例疗效观察[J]. 药品评价, 2021, 18(1):44-47. |
WEN W, HUANG J H, LIU Y Q, et al. Observation on the curative effect of Shenqu Xiaoshi Oral liquid combined with zinc preparation in the treatment of 50 cases of infantile diarrhea[J]. Drug Evaluation, 2021, 18(1):44-47. doi:10.19939/j.cnki.1672-2809.2021.01.13. | |
[14] | 宁启国, 陈娜. 双歧杆菌四联活菌联合干扰素对轮状病毒感染性腹泻患儿炎性因子、免疫功能与肠道菌群的影响[J]. 延安大学学报(医学科学版), 2023, 21(2):83-86. |
NING Q G, CHEN N. Effects of bifidobacterium tetravaccine live combined with interferon on inflammatory factors,immune function and intestinal flora in children with rotavirus infectious diarrhea[J]. Journal of Yanan University(Medical Sciences), 2023, 21(2):83-86. doi:10.19893/j.cnki.ydyxb.2023-0066. | |
[15] | 路钰夏, 杨辉, 王向辉, 等. 病毒感染性腹泻对儿童人群肠道菌群及IL-6、TNF-α、hs-CRP、IFN-γ水平的影响[J]. 中国实验诊断学, 2022, 26(6):842-846. |
LU Y X, YANG H, WANG X H, et al. Effect of virus-infected diarrhea on intestinal flora and levels of IL-6,TNF-α,hs-CRP and IFN-γ in children[J]. Chinese Journal of Laboratory Diagnosis, 2022, 26(6):842-846. doi:10.3969/j.issn.1007-4287.2022.06.014. | |
[16] | 尚小玉, 聂楠. CRP、心肌酶谱、肝功能检测在小儿轮状病毒感染性腹泻诊治中的应用价值[J]. 贵州医药, 2021, 45(3):454-455. |
SHANG X Y, NIE N. Application value of CRP,myocardial enzyme profile and liver function detection in diagnosis and treatment of rotavirus infected diarrhea in children[J]. Guizhou Medicine, 2021, 45(3):454-455. doi:10.3969/j.issn.1000-744X.2021.03.061. | |
[17] | 张根民. 神曲消食口服液治疗小儿腹泻的疗效及其对IL-6、TNF-α水平的影响[J]. 北方药学, 2019, 16(3):142-143. |
ZHANG G M. Effect of Shenqu Xiaoshi oral liquid on diarrhea in children and its effect on IL-6 and TNF-α levels[J]. Journal of Northern Medicine, 2019, 16(3):142-143. doi:10.3969/j.issn.1672-8351.2019.03.109. | |
[18] | 吕立铭, 彭崇胜, 李晓波. 山楂核化学成分、药理作用及应用研究进展[J]. 沈阳药科大学学报, 2022, 39(12):1521-1532. |
LV L M, PENG C S, LI X B. Research progress in chemical ingredients,pharmacological activities and application of hawthorn seeds[J]. Journal of Shenyang Pharmaceutical University, 2022, 39(12):1521-1532. doi:10.14066/j.cnki.cn21-1349/r.2021.0772. | |
[19] | 辛卫云, 白明, 苗明三. 麦芽的现代研究[J]. 中医学报, 2017, 32(4):613-615. |
XIN W Y, BAI M, MIAO M S. Modern study analysis on malt[J]. China Journal of Chinese Medicine, 2017, 32(4):613-615. doi:10.16368/j.issn.1674-8999.2017.04.160. | |
[20] | 肖瑞瑶, 滕攀攀, 綦世金, 等. 党参多糖对肠道微生态及肠道疾病作用研究进展[J]. 微生物学通报, 2023, 50(2):687-696. |
XIAO R Y, TENG P P, QI S J, et al. Research progress in the effect of Codonopsis pilosula polysaccharide on intestinal microecology and intestinal diseases[J]. Microbiology China, 2023, 50(2):687-696. doi:10.13344/j.microbiol.china.220461. | |
[21] | 左军, 祁天立, 胡晓阳. 茯苓化学成分及现代药理研究进展[J]. 中医药学报, 2023, 51(1):110-114. |
ZUO J, QI T L, HU X Y. Research progress in chemical constituents and modern pharmacology of Poria Cocos[J]. Acta Chinese Medicine and Pharmacology, 2023, 51(1):110-114. doi:10.19664/j.cnki.1002-2392.230022. |
[1] | SHAN Zihong, HU Xiaoqing, LI Feng, HUANG Yongkun. Research progress on the role and mechanism of 5-hydroxytryptamine in gastrointestinal diseases [J]. Tianjin Medical Journal, 2024, 52(4): 438-442. |
[2] | ZHANG Jie, MIAO Naiying, LI Huan, LIU Xinjian. Effects of octreotide on fecal characteristics and humoral immunity in neonates with necrotizing enterocolitis [J]. Tianjin Medical Journal, 2024, 52(12): 1331-1334. |
[3] | QIN Zongbi, XU Aiqin, CAI Xiang, QIU Baiyi, WANG Shoufan, LI Linghua, ZHU Lihong. Effects of berberine on skin damage in rats with chronic eczema by regulating PI3K/AKT/NF-κB signaling pathway [J]. Tianjin Medical Journal, 2023, 51(8): 834-840. |
[4] | ZHANG Xiaoyu, REN Yue, LIU Wei, MIAO Yanling, ZHANG Hui, JIN Lijun, ZHANG Hengle, KANG Xiaoning, BAI Jie, WANG Zunyi. Clinical efficacy of neoadjuvant chemotherapy combined with PD-1 inhibitor in the treatment of triple negative breast cancer [J]. Tianjin Medical Journal, 2023, 51(8): 847-850. |
[5] | WANG Hongjun, SUN Xingxing, ZHANG Runlian. Study on the effect of Shengyang Yiwei Decoction on the immune function of rats with lung cancer based on PI3K/Akt/NF-κB signal pathway [J]. Tianjin Medical Journal, 2023, 51(7): 739-745. |
[6] | YANG Yutao, WANG Yuan, XIE Jiaxin, FU Xiafei. Isolation, identification and ovarian uptake of exosomes derived from human bone marrow mesenchymal stem cells [J]. Tianjin Medical Journal, 2023, 51(5): 468-472. |
[7] | LI Jianbin, HAN Ting, WU Rui. Exploring the correlation between immune function and poor prognosis in alloimmune recurrent miscarriage [J]. Tianjin Medical Journal, 2023, 51(11): 1217-1220. |
[8] | SHI Jingxiang, CAO Jisen, ZHANG Jinjuan, WANG Yijun. Research progress of interleukin 22 binding protein in inflammation related diseases [J]. Tianjin Medical Journal, 2023, 51(1): 109-112. |
[9] | DU Peng, WANG Feng, CHEN Xiaobo, ZHENG Yan, WU Qianqian, LIU Weijun, WANG Yuliang. Impact of age on the biological properties of human adipose tissue-derived mesenchymal stromal cells [J]. Tianjin Medical Journal, 2022, 50(9): 912-916. |
[10] | WANG Zhi-ying, YANG Qiu-xia, TIAN Xin-li, LIN Xue-xia△. Study on the mechanism of silicon-containing hydroxyapatite regulating macrophage [J]. Tianjin Medical Journal, 2021, 49(9): 910-915. |
[11] | LIN Min-qing, XIA Wen-guang, XU Bo, XU Ai-ping, WANG Ye-ming△. Clinical Significance of T-Lymphocyte Subsets in the Treatment of COVID-19 [J]. Tianjin Medical Journal, 2020, 48(6): 499-503. |
[12] | CHEN Si-min, MAO Jie, CHEN Zhi-ru. dietary fiber|diarrhea|aged|probiotics|soluble dietary fiber|antibiotic associated diarrhea [J]. Tianjin Medical Journal, 2018, 46(3): 284-287. |
[13] | YU Hong-zhi, WU Qi. The new progress of intestinal microbiome and lung diseases [J]. Tianjin Med J, 2017, 45(6): 668-672. |
[14] | XIA Lin-lin1, YANG Jie1, HUAN Juan1, GE Hong-yu2, ZHAO Zhan1, LIU Xiao-xia1, WANG Yu-bao1△. Antibiotics resistance of Proteus mirabilis isolated from patients with acute diarrhea [J]. Tianjin Med J, 2017, 45(12): 1266-1270. |
[15] | WANG Gengzhuang1, ZHAO Zhirong2, PAN Lifeng1. A comparative study of laparoscopic neoplasty and open neoplasty on levels of procalcitonin and cell-mediated immunity in elderly patients with upper digestive tract ulcer perforation [J]. Tianjin Med J, 2016, 44(6): 772-775. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||